Preclinical and clinical progress in hemophilia gene therapy

Current Opinion in Hematology
Janka MátraiThierry VandenDriessche

Abstract

Hemophilia A and B are attractive target diseases for gene therapy, as stable expression of coagulation factor VIII and IX may correct the bleeding diathesis. This review focuses on the recent progress in preclinical and clinical studies in gene therapy for hemophilia A and B. Hepatic gene delivery using vectors derived from adeno-associated virus (AAV) resulted in therapeutic but transient functional clotting factor IX (FIX) expression levels in severe hemophilia B patients. Although T-cell-mediated immune responses eliminated the transduced hepatocytes, transient immunosuppression may potentially overcome this limitation. Alternatively, vectors are being developed that result in higher FIX expression levels at lower vector doses. Lentiviral vectors are being explored for in-vivo hepatic gene delivery and for ex-vivo transduction of hematopoietic stem cells. This resulted in stable correction of the bleeding diathesis in hemophilic mice. Finally, nonviral vectors derived from transposons result in sustained clotting-factor expression in rodent models. Translational studies in large animal models are required to move these new approaches forward into the clinic. New insights from clinical trials and advances in preclinical stud...Continue Reading

References

Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·T VandenDriesscheM K Chuah
Jun 16, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·C S SteinP B McCray
Aug 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Guang-Ping GaoJames M Wilson
Jan 17, 2003·The New England Journal of Medicine·Salima Hacein-Bey-AbinaAlain Fischer
May 28, 2004·Journal of Virology·Guangping GaoJames M Wilson
Apr 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Lingfei XuKatherine P Ponder
May 11, 2006·Haemophilia : the Official Journal of the World Federation of Hemophilia·D LillicrapK High
Jul 11, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Haiyan JiangValder R Arruda
Jul 11, 2006·The Journal of Clinical Investigation·Qizhen ShiRobert R Montgomery
Jul 18, 2006·Nature Biotechnology·Alex H ChangMichel Sadelain
Jul 18, 2006·Nature Medicine·Luk H VandenbergheJames M Wilson
Aug 5, 2006·Current Opinion in Hematology·Katherine P Ponder
Jan 25, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hua LiHildegund Cj Ertl
Feb 3, 2007·Journal of Thrombosis and Haemostasis : JTH·Q ShiR R Montgomery
Mar 21, 2007·Nature Medicine·Federico MingozziKatherine A High
Mar 28, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christopher B DoeringH Trent Spencer
Apr 27, 2007·Journal of Thrombosis and Haemostasis : JTH·G F PierceT Vandendriessche
Dec 7, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zhijian WuPaul E Monahan
Feb 16, 2008·British Journal of Haematology·Samuel L Murphy, Katherine A High
Apr 29, 2008·The New England Journal of Medicine·Albert M MaguireJean Bennett
Apr 29, 2008·The New England Journal of Medicine·James W B BainbridgeRobin R Ali
Apr 29, 2008·The New England Journal of Medicine·Joan W Miller
May 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·Li ZhongArun Srivastava
Jun 5, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tsukasa OhmoriYoichi Sakata
Aug 7, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alex H ChangMichel Sadelain
Oct 23, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Bernd HauckJ Fraser Wright
Jan 31, 2009·The New England Journal of Medicine·Alessandro AiutiMaria-Grazia Roncarolo
Jan 31, 2009·The New England Journal of Medicine·Donald B Kohn, Fabio Candotti
Mar 5, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christopher B DoeringH Trent Spencer
Mar 25, 2009·Human Gene Therapy·Mario CooperRoland W Herzog

❮ Previous
Next ❯

Citations

Feb 10, 2011·PloS One·A Jennifer Morton, Laura Avanzo
Jan 6, 2011·Expert Opinion on Biological Therapy·Luc J W van der LaanQiuwei Pan
Mar 1, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Klaas PoelstraLeonie Beljaars
May 31, 2012·Journal of Thrombosis and Haemostasis : JTH·M K Chuah, T Vandendriessche
Jul 17, 2013·Journal of Thrombosis and Haemostasis : JTH·M K ChuahT VandenDriessche
May 30, 2015·Colloids and Surfaces. B, Biointerfaces·Ali Dehshahri, Hossein Sadeghpour
Jun 8, 2012·Human Gene Therapy·Marinee K ChuahThierry VandenDriessche
Aug 11, 2017·Human Gene Therapy·Thierry VandenDriessche, Marinee K Chuah
Jul 31, 2020·Cancer Reports·Ankur SharmaKavindra Kumar Kesari
Jun 8, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·H EvensT VandenDriessche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.